HER2-NEGATIVE BREAST CANCER
Clinical trials for HER2-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New device trial offers hope for advanced breast cancer patients out of options
Disease control Not yet recruitingThis study is testing a device called TheraBionic P1 to see if it can help control advanced breast cancer and help patients live longer. It is for women whose cancer has spread and has stopped responding to standard hormone therapies and chemotherapy. The device is held in the mo…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Heating tumors to boost immune attack on advanced breast cancer
Disease control Not yet recruitingThis study is testing whether using heat therapy on breast cancer tumors that have spread to the liver, combined with immunotherapy drugs, can help control the disease. It is for women with advanced HER2-negative breast cancer whose cancer has continued to grow despite previous t…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Blood test could spare breast cancer patients from harsh chemo
Disease control Not yet recruitingThis study is testing a personalized approach to treat early-stage, hormone-sensitive breast cancer. Before surgery, patients receive a combination of targeted pills instead of standard chemotherapy. Doctors will use a simple blood test to check for cancer DNA. If the blood test …
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New hope for Tough-to-Treat breast cancer: testing a powerful drug duo
Disease control Not yet recruitingThis study is testing whether combining two drugs, elacestrant and trastuzumab deruxtecan, can help control advanced breast cancer that has grown despite prior hormone-based therapies. It will involve about 65 people with specific types of breast cancer (HR+/HER2-low or ultralow)…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sarah Sammons, MD • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC